315 related articles for article (PubMed ID: 30761088)
1. Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy.
Bhusal A; Rahman MH; Lee IK; Suk K
Front Endocrinol (Lausanne); 2019; 10():25. PubMed ID: 30761088
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia.
Kim JH; Ko PW; Lee HW; Jeong JY; Lee MG; Kim JH; Lee WH; Yu R; Oh WJ; Suk K
Glia; 2017 Sep; 65(9):1471-1490. PubMed ID: 28581123
[TBL] [Abstract][Full Text] [Related]
3. Research Progress on Lipocalin-2 in Diabetic Encephalopathy.
Zhang W; Chen S; Zhuang X
Neuroscience; 2023 Apr; 515():74-82. PubMed ID: 36805002
[TBL] [Abstract][Full Text] [Related]
4. Tonicity-responsive enhancer-binding protein promotes diabetic neuroinflammation and cognitive impairment via upregulation of lipocalin-2.
Jeong EA; Lee J; Shin HJ; Lee JY; Kim KE; An HS; Kim DR; Choi KY; Lee KH; Roh GS
J Neuroinflammation; 2021 Nov; 18(1):278. PubMed ID: 34844610
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 Deficiency Reduces Hepatic and Hippocampal Triggering Receptor Expressed on Myeloid Cells-2 Expressions in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
Shin HJ; Jin Z; An HS; Park G; Lee JY; Lee SJ; Jang HM; Jeong EA; Kim KE; Lee J; Yoo DY; Roh GS
Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884685
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
[TBL] [Abstract][Full Text] [Related]
7. Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment.
Olson B; Zhu X; Norgard MA; Diba P; Levasseur PR; Buenafe AC; Huisman C; Burfeind KG; Michaelis KA; Kong G; Braun T; Marks DL
Brain Behav Immun; 2021 Oct; 97():102-118. PubMed ID: 34245812
[TBL] [Abstract][Full Text] [Related]
8. Satellite glia as a critical component of diabetic neuropathy: Role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion.
Bhusal A; Rahman MH; Lee WH; Lee IK; Suk K
Glia; 2021 Apr; 69(4):971-996. PubMed ID: 33251681
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation Induced by Transgenic Expression of Lipocalin-2 in Astrocytes.
Kim JH; Kwon O; Bhusal A; Lee J; Hwang EM; Ryu H; Park JY; Suk K
Front Cell Neurosci; 2022; 16():839118. PubMed ID: 35281301
[TBL] [Abstract][Full Text] [Related]
10. Role of lipocalin-2 in surgery-induced cognitive decline in mice: a signal from neuron to microglia.
Xiang X; Tang X; Yu Y; Xie S; Liu L; Chen M; Zhang R; Kang X; Zheng Y; Yang G; Gan S; Zhu S
J Neuroinflammation; 2022 Apr; 19(1):92. PubMed ID: 35413913
[TBL] [Abstract][Full Text] [Related]
11. Lipocalin-2 Is a Key Regulator of Neuroinflammation in Secondary Traumatic and Ischemic Brain Injury.
Kim JH; Kang RJ; Hyeon SJ; Ryu H; Joo H; Bu Y; Kim JH; Suk K
Neurotherapeutics; 2023 Apr; 20(3):803-821. PubMed ID: 36508119
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2 Acts as a Neuroinflammatogen in Lipopolysaccharide-injected Mice.
Jin M; Jang E; Suk K
Exp Neurobiol; 2014 Jun; 23(2):155-62. PubMed ID: 24963280
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 as a Putative Modulator of Local Inflammatory Processes in the Spinal Cord and Component of Organ Cross talk After Spinal Cord Injury.
Behrens V; Voelz C; Müller N; Zhao W; Gasterich N; Clarner T; Beyer C; Zendedel A
Mol Neurobiol; 2021 Nov; 58(11):5907-5919. PubMed ID: 34417948
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 17A deficiency alleviates neuroinflammation and cognitive impairment in an experimental model of diabetic encephalopathy.
Fang XX; Xu FF; Liu Z; Cao BB; Qiu YH; Peng YP
Neural Regen Res; 2022 Dec; 17(12):2771-2777. PubMed ID: 35662228
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration.
Ip JP; Noçon AL; Hofer MJ; Lim SL; Müller M; Campbell IL
J Neuroinflammation; 2011 Sep; 8():124. PubMed ID: 21943033
[TBL] [Abstract][Full Text] [Related]
18. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role played by lipocalin-2 in chronic inflammatory pain.
Jha MK; Jeon S; Jin M; Ock J; Kim JH; Lee WH; Suk K
Exp Neurol; 2014 Apr; 254():41-53. PubMed ID: 24440229
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2 Is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration.
Lee S; Kim JH; Kim JH; Seo JW; Han HS; Lee WH; Mori K; Nakao K; Barasch J; Suk K
J Biol Chem; 2011 Dec; 286(51):43855-43870. PubMed ID: 22030398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
